Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease
Extracranial-to-intracranial (EC-IC) bypass surgery is an effective treatment for patients with moyamoya disease and other conditions. Some patients with moyamoya disease have a risk of acute thrombogenesis at the anastomotic site just after bypass surgery. The purpose of this study was to study risk factors of acute thrombogenesis and determine effective countermeasures. This study included 48 patients (66 EC-IC bypass procedures) with moyamoya disease and 52 controls (54 procedures) without moyamoya disease. The development of acute thrombogenesis was compared between the moyamoya disease and control groups. In the moyamoya disease group, clinical and radiological characteristics were assessed with respect to acute thrombogenesis. In the patients with acute thrombogenesis, causes of technical problems were retrospectively examined. The incidence of acute thrombogenesis was significantly higher in the moyamoya disease group than those in the control group. In the moyamoya disease group, acute thrombogenesis was observed in seven patients. In the moyamoya disease group, the magnetic resonance angiography (MRA) scores were significantly higher in patients with acute thrombogenesis than those in the patients without acute thrombogenesis. In the multivariate analysis, the predictive factor of acute thrombogenesis in moyamoya disease was a high MRA score (odds ratio, 2.336; p = 0.009). During EC-IC bypass surgery for moyamoya disease, acute thrombogenesis should be considered to obtain a high patency rate, particularly in patients with high MRA scores. Acute thrombogenesis will not influence morbidity if proper countermeasures are followed; therefore, the prediction and recognition of white thrombus are important for a successful bypass surgery.
KeywordsMoyamoya disease Bypass Thrombogenesis Complication
No funding was received for this study.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
We declare that this study has been approved by the Ethics Committee of the Sapporo Medical University Hospital (no. 282-166) and was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.
All the patients provided informed consent before participation.
- 3.Deng X, Gao F, Zhang D, Zhang Y, Wang R, Wang S, Cao Y, Zhao Y, Pan Y, Ye X, Liu X, Zhang Q, Wang J, Yang Z, Zhao M, Zhao J (2018) Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study. J Neurosurg 128:1327–1337. https://doi.org/10.3171/2016.12.jns162626 CrossRefPubMedGoogle Scholar
- 5.Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T (2012) Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis (Basel, Switzerland) 33:436–445. https://doi.org/10.1159/000336765 CrossRefGoogle Scholar
- 6.Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, Tomata Y, Miyamoto S (2018) Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 128:777–784. https://doi.org/10.3171/2016.11.jns161650 CrossRefPubMedGoogle Scholar
- 8.Gu Y, Ni W, Jiang H, Ning G, Xu B, Tian Y, Xu F, Liao Y, Song D, Mao Y (2012) Efficacy of extracranial-intracranial revascularization for non-moyamoya steno-occlusive cerebrovascular disease in a series of 66 patients. J Clin Neurosci 19:1408–1415. https://doi.org/10.1016/j.jocn.2011.11.037 CrossRefPubMedGoogle Scholar
- 10.Han JS, Abou-Hamden A, Mandell DM, Poublanc J, Crawley AP, Fisher JA, Mikulis DJ, Tymianski M (2011) Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke 42:3047–3054. https://doi.org/10.1161/strokeaha.111.615955 CrossRefPubMedGoogle Scholar
- 17.Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H (2014) The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg 121:432–440. https://doi.org/10.3171/2014.1.jns13946 CrossRefPubMedGoogle Scholar
- 19.Komatsu K, Mikami T, Noshiro S, Miyata K, Wanibuchi M, Mikuni N (2016) Reversibility of white matter hyperintensity by revascularization surgery in moyamoya disease. J Stroke Cerebrovasc Dis 25:1495–1502. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.02.035 CrossRefPubMedGoogle Scholar
- 22.Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC (2014) Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 45:1415–1421. https://doi.org/10.1161/strokeaha.113.004386 CrossRefPubMedGoogle Scholar
- 25.Onozuka D, Hagihara A, Nishimura K, Kada A, Nakagawara J, Ogasawara K, Ono J, Shiokawa Y, Aruga T, Miyachi S, Nagata I, Toyoda K, Matsuda S, Suzuki A, Kataoka H, Nakamura F, Kamitani S, Nishimura A, Kurogi R, Sayama T, Iihara K (2016) Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study). BMJ Open 6:e009942. https://doi.org/10.1136/bmjopen-2015-009942 CrossRefPubMedGoogle Scholar
- 28.Schubert GA, Biermann P, Weiss C, Seiz M, Vajkoczy P, Schmiedek P, Thome C (2014) Risk profile in extracranial/intracranial bypass surgery—the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures. World Neurosurg 82:672–677. https://doi.org/10.1016/j.wneu.2013.06.010 CrossRefPubMedGoogle Scholar
- 32.Zhao M, Deng X, Zhang D, Wang S, Zhang Y, Wang R, Zhao J (2018) Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. J Neurosurg:1–12. https://doi.org/10.3171/2017.10.jns171749